Individual #00004528

ID_report -
Reference PubMed: van Karnebeek 2014
Remarks 2-generation family, 1 affectd, unaffected heterozygous carrier parents
Gender M
Consanguinity no
Country Russian Federation
Population -
Age at death -
VIP -
Data_av -
Treatment -
Panel size 1
Diseases CA5AD
Owner name Clara van Karnebeek
Database submission license No license selected
Created by Clara van Karnebeek
Date created 2014-01-28 22:33:58 +01:00 (CET)
Date last edited 2014-06-18 22:47:35 +02:00 (CEST)


Phenotypes

deficiency, carbonic anhydrase VA, hyperammonemia (CA5AD) (CA5AD)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000015944 a male child was born spontaneously at gestational age 36+2 weeks to non-consanguineous Russian parents. On Day 4 of life, he presented with lethargy, weight loss (15% below birth weight), jaundice, and tachypnea. Initial investigations showed hyperammonemia (316 and 422 mol/L), hyperlactatemia (8.1 mmol/L), mild hypoglycaemia (2.9 mmol/L), metabolic acidosis (pH: 7.16, pCO2 13 mm Hg, HCO3 - 5mEq/l), and ketonuria. Despite fluid resuscitation, sodium bicarbonate infusion, and antibiotics, the neonate’s clinical and biochemical status deteriorated; liver transaminases and synthetic function remained normal. Metabolic investigations are shown in Table 1; molecular analysis of CPS1 and NAGS did not reveal disease-causing mutations. Carglumic acid and biotin were initiated, along with protein-free formula and intravenous lipids; 12 hours later, the metabolic acidosis and hyperammonemia resolved. He resumed breastfeeding with normal weight gain, ammonia levels, and urine metabolites. Carglumic acid was stopped at 4 months of age, and the infant exhibited normal psychomotor development at age 6m with the use of sick-day formula during illness. - - Familial, autosomal recessive - - - - - Clara van Karnebeek



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000004443 DNA;RNA RT-PCR;SEQ;SEQ-NG-I Fibroblast - CA5A 1 Clara van Karnebeek



Variants

1 entry on 1 page. Showing entry 1.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
16 Both (homozygous) +?/+ - likely pathogenic g.87936031C>T g.87902425C>T - - CA5A_000001 Lead to skipping of exon 4 PubMed: van Karnebeek 2014 - - Germline yes - - - - Clara van Karnebeek CA5A - - - - 4 NM_001739.1:c.555G>A - r.460_555del p.Leu154_Lys185del - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.